$143 Million is the total value of Northpond Ventures, LLC's 5 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DICE THERAPEUTICS INC | $66,779,000 | +30.7% | 3,292,871 | 0.0% | 46.80% | -3.9% | ||
VIGIL NEUROSCIENCE INC | $38,352,000 | +252.7% | 4,214,498 | 0.0% | 26.88% | +159.5% | ||
DNAY | CODEX DNA INC | $16,341,000 | -7.8% | 9,844,130 | 0.0% | 11.45% | -32.1% | |
ISOPLEXIS CORP | $15,151,000 | -20.4% | 8,808,531 | 0.0% | 10.62% | -41.4% | ||
CANDEL THERAPEUTICS INC | $6,077,000 | -3.1% | 1,935,215 | 0.0% | 4.26% | -28.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TELESIS BIO INC | 8 | Q3 2023 | 37.2% |
CANDEL THERAPEUTICS INC | 8 | Q3 2023 | 6.0% |
VIGIL NEUROSCIENCE INC | 7 | Q3 2023 | 65.8% |
DICE THERAPEUTICS INC | 6 | Q1 2023 | 55.7% |
ISOPLEXIS CORP | 5 | Q4 2022 | 28.3% |
PHENOMEX INC | 2 | Q2 2023 | 4.4% |
View Northpond Ventures, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-06-02 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-01 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-01 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
View Northpond Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.